跳至主要内容
临床试验/NCT03211260
NCT03211260终止不适用

Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease: a Open, Single-arm Trial

ASST Gaetano Pini-CTO1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2017年12月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
42
试验地点
1
主要终点
Freezing of gait questionnaire severity

研究概览

简要总结

Freezing of gait (FOG) is a common disabling condition in Parkinson's disease (PD), causes falls, and impairs quality of life. Therapeutic options for this symptom are limited and of limited efficacy. Besides, the pathophysiology has been not clarified yet. Proprioceptive sensitivity is likely to play a role and recent studies have reported that high-frequency microfocal vibratory stimulation exert a modulatory effect of proprioceptive reflex circuits and could be considered a valuable treatment strategy. However, evidence is not available. The present study was designed to collect preliminary evidence of efficacy of a vibrotactile device (Equistasi) for the treatment of FOG.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient with Parkinson's Disease
  • Stable drug therapy response without any change in the 3 months before the study.
  • written informed consent

排除标准

  • Hoehn-Yahr stage ≥ 4
  • Cognitive decline (Mini Mental State Examination <26)
  • Systemic illness involving the nervous system
  • Presence of cardiac pacemaker
  • Presence of deep brain stimulation
  • Presence of severe dysautonomia with marked hypotension
  • History or active neoplasia
  • Pregnancy

研究组 & 干预措施

EQUISTASI

Experimental

Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive four patches to be placed on both legs for 4 weeks.

干预措施: EQUISTASI (Device)

结局指标

主要结局

Freezing of gait questionnaire severity

时间窗: 4 weeks

Change in freezing of gait questionnaire score

次要结局

  • Gait and Falls Questionnaire (GFQ) score(4 weeks)
  • 39-item Parkinson's Disease Questionnaire(4 weeks)
  • Treatment continuation(4 weeks)
  • Falls(4 weeks)

研究者

发起方
ASST Gaetano Pini-CTO
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gianni Pezzoli

Principal Investigator

ASST Gaetano Pini-CTO

研究点 (1)

Loading locations...

相似试验